AbbVie has agreed to acquire Gilgamesh Pharmaceuticals Inc.’s lead investigational candidate, currently in clinical ...

Ken McFarlane of CluePoints shares insight on better, smarter ways to detect risk, streamline data review, and automate ...

Bio-Rad Laboratories has introduced a new range of StarBright Dyes, providing greater choice and flexibility for spectral ...

With over two decades of experience, Katcheves previously served at Teva, Bristol Myers Squibb, and Lonza Group.

The European Commission (EC) has approved Bio-Thera Solutions Inc.’s BAT2206 (ustekinumab), a biosimilar referencing Stelara.

The European Commission has granted marketing authorization for Yeytuo (lenacapavir)—Gilead Sciences Inc.’s twice-yearly ...